195 related articles for article (PubMed ID: 23275339)
1. Peroxisome proliferator-activated receptor γ agonists induce cell cycle arrest through transcriptional regulation of Kruppel-like factor 4 (KLF4).
Li S; Zhou Q; He H; Zhao Y; Liu Z
J Biol Chem; 2013 Feb; 288(6):4076-84. PubMed ID: 23275339
[TBL] [Abstract][Full Text] [Related]
2. MCC-555-induced NAG-1 expression is mediated in part by KLF4.
Cekanova M; Lee SH; McEntee MF; Baek SJ
Eur J Pharmacol; 2010 Jul; 637(1-3):30-7. PubMed ID: 20385121
[TBL] [Abstract][Full Text] [Related]
3. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
4. A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4.
Min KW; Zhang X; Imchen T; Baek SJ
Toxicol Appl Pharmacol; 2012 Sep; 263(2):225-32. PubMed ID: 22750490
[TBL] [Abstract][Full Text] [Related]
5. Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression.
Rovito D; Gionfriddo G; Barone I; Giordano C; Grande F; De Amicis F; Lanzino M; Catalano S; Andò S; Bonofiglio D
Oncotarget; 2016 Oct; 7(40):65109-65124. PubMed ID: 27556298
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
Araki O; Ying H; Furuya F; Zhu X; Cheng SY
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
[TBL] [Abstract][Full Text] [Related]
7. KLF4-dependent, PPARgamma-induced expression of GPA33 in colon cancer cell lines.
Rageul J; Mottier S; Jarry A; Shah Y; Théoleyre S; Masson D; Gonzalez FJ; Laboisse CL; Denis MG
Int J Cancer; 2009 Dec; 125(12):2802-9. PubMed ID: 19551868
[TBL] [Abstract][Full Text] [Related]
8. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.
Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L
Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939
[TBL] [Abstract][Full Text] [Related]
9. CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
Faber K; Bullinger L; Ragu C; Garding A; Mertens D; Miller C; Martin D; Walcher D; Döhner K; Döhner H; Claus R; Plass C; Sykes SM; Lane SW; Scholl C; Fröhling S
J Clin Invest; 2013 Jan; 123(1):299-314. PubMed ID: 23202735
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
[TBL] [Abstract][Full Text] [Related]
11. 2 dyn/cm
Chang SF; Huang KC; Chang HI; Lee KC; Su YP; Chen CN
J Cell Physiol; 2018 Jan; 234(1):958-968. PubMed ID: 30132856
[TBL] [Abstract][Full Text] [Related]
12. FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes.
Fan W; Imamura T; Sonoda N; Sears DD; Patsouris D; Kim JJ; Olefsky JM
J Biol Chem; 2009 May; 284(18):12188-97. PubMed ID: 19246449
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor gamma in mammary epithelial cells upregulates the expression of tumor suppressor Cyld to mediate growth inhibition and anti-inflammatory effects.
Pseftogas A; Gonidas C; Mosialos G
Int J Biochem Cell Biol; 2017 Jan; 82():49-56. PubMed ID: 27865894
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
Han S; Sidell N; Fisher PB; Roman J
Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
[TBL] [Abstract][Full Text] [Related]
15. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
Tang Q; Wu J; Zheng F; Hann SS; Chen Y
Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional Regulation of Human Cytosolic Sulfotransferase 1C3 by Peroxisome Proliferator-Activated Receptor γ in LS180 Human Colorectal Adenocarcinoma Cells.
Dubaisi S; Fang H; Kocarek TA; Runge-Morris M
Mol Pharmacol; 2016 Nov; 90(5):562-569. PubMed ID: 27565680
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY; Cho IJ; Kim SG
Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
[TBL] [Abstract][Full Text] [Related]
18. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells.
Lovekamp-Swan T; Chaffin CL
Mol Cell Endocrinol; 2005 Apr; 233(1-2):15-24. PubMed ID: 15767042
[TBL] [Abstract][Full Text] [Related]
19. The Pal3 promoter sequence is critical for the regulation of human renin gene transcription by peroxisome proliferator-activated receptor-gamma.
Todorov VT; Desch M; Schubert T; Kurtz A
Endocrinology; 2008 Sep; 149(9):4647-57. PubMed ID: 18483152
[TBL] [Abstract][Full Text] [Related]
20. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
